Allergy

BOSTON — The TIDE-Asthma study used specific enrollment strategies to increase study population diversity, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Healio has compiled November’s most read news in asthma and allergy.

BOSTON — Patients with chronic rhinosinusitis with nasal polyps showed low biologics use and high discontinuation rates, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Roflumilast cream improved signs and symptoms of atopic dermatitis, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Patients using lipid-lowering medications experienced increased anaphylaxis severity, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Allergen-related symptoms resolved within 5 minutes after an oral allergen challenge with the Anaphylm sublingual epinephrine strip from Aquestive Therapeutics, according to a press release from the company.

BOSTON — Infants who took nirsevimab had a reduced risk for respiratory syncytial virus lower respiratory tract disease, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Aisha Mohammed, MD, was led to the field of medicine with a specific focus on underserved communities after witnessing her mother’s challenges in accessing care.

BOSTON — Consensus criteria for anaphylaxis diagnosis are moving toward more objective assessments of symptoms, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Using virtual asthma coaching improved asthma control in poorly controlled patients, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.